iSpecimen (NASDAQ:ISPC – Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Tuesday, May 7th. Investors interested in participating in the company’s conference call can do so using this link.
iSpecimen (NASDAQ:ISPC – Get Free Report) last posted its earnings results on Wednesday, March 13th. The company reported ($0.34) earnings per share (EPS) for the quarter. The company had revenue of $2.58 million during the quarter. iSpecimen had a negative net margin of 111.81% and a negative return on equity of 80.37%.
iSpecimen Stock Down 1.3 %
Shares of ISPC stock opened at $0.26 on Monday. The business’s fifty day simple moving average is $0.31 and its 200-day simple moving average is $0.44. iSpecimen has a 12-month low of $0.20 and a 12-month high of $1.89.
iSpecimen Company Profile
iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.
Read More
- Five stocks we like better than iSpecimen
- What is the Euro STOXX 50 Index?
- 3 Value Stocks You Can Buy Before They Become Big
- Stock Average Calculator
- Chinese Stocks Stage Impressive Rebound
- How to Use the MarketBeat Stock Screener
- Coca-Cola Stock Analysis: Key Insights and Trends
Receive News & Ratings for iSpecimen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iSpecimen and related companies with MarketBeat.com's FREE daily email newsletter.
